James Sidoti
Stock Analyst at Sidoti & Co.
(3.02)
# 1,390
Out of 4,975 analysts
9
Total ratings
60%
Success rate
71.66%
Average return
Main Sectors:
Stocks Rated by James Sidoti
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STAA STAAR Surgical Company | Downgrades: Neutral | $27 → $28 | $27.94 | +0.21% | 3 | Aug 5, 2025 | |
| SRDX Surmodics | Downgrades: Neutral | $43 | $32.34 | +32.98% | 1 | May 29, 2024 | |
| CODX Co-Diagnostics | Downgrades: Neutral | $5 | $0.31 | +1,513.94% | 1 | Aug 12, 2022 | |
| LMAT LeMaitre Vascular | Maintains: Buy | $38 → $34 | $97.88 | -65.26% | 2 | Apr 8, 2020 | |
| ANIK Anika Therapeutics | Upgrades: Buy | $61 | $8.91 | +584.62% | 2 | Jan 21, 2020 |
STAAR Surgical Company
Aug 5, 2025
Downgrades: Neutral
Price Target: $27 → $28
Current: $27.94
Upside: +0.21%
Surmodics
May 29, 2024
Downgrades: Neutral
Price Target: $43
Current: $32.34
Upside: +32.98%
Co-Diagnostics
Aug 12, 2022
Downgrades: Neutral
Price Target: $5
Current: $0.31
Upside: +1,513.94%
LeMaitre Vascular
Apr 8, 2020
Maintains: Buy
Price Target: $38 → $34
Current: $97.88
Upside: -65.26%
Anika Therapeutics
Jan 21, 2020
Upgrades: Buy
Price Target: $61
Current: $8.91
Upside: +584.62%